Previous studies have confirmed that CEP55 expression could distinguish cancers from control tissues in 21 cancer types [15], including hepatocellular [16], breast [17], liver [18], colorectal [19], lung cancer [20], etc., but CEP55 expression is not well documented in glioma, especially GBM [15,21–24]. Here, CEP55 is linked to central nervous system cancer.